loading . . . ORYZON reports financial results and corporate update for half-year ending June 30, 2025 | Oryzon MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, July 30th, 2025 – Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics,... https://www.oryzon.com/en/news-events/news/oryzon-reports-financial-results-and-corporate-update-half-year-ending-june-30-0